Information Provided By:
Fly News Breaks for July 16, 2019
Jul 16, 2019 | 07:35 EDT
As previously reported, Bernstein analyst Aaron Gal downgraded Allergan (AGN) to Market Perform from Outperform as spread seems fair given sector volatility. The analyst notes that Allergan stock stabilized at about $165 reflecting 9% spread versus takeout price at current Abbvie (ABBV) stock price and 75%-80% odds the deal will close